| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 11183719
[patent_doc_number] => 09415105
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-16
[patent_title] => 'Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation'
[patent_app_type] => utility
[patent_app_number] => 14/067005
[patent_app_country] => US
[patent_app_date] => 2013-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 30
[patent_no_of_words] => 20415
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14067005
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/067005 | Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation | Oct 29, 2013 | Issued |
Array
(
[id] => 9450191
[patent_doc_number] => 20140121361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'NOVEL N3S1 CHELATOR-FOLATE DERIVATIVES, PREPARATION METHOD THEREOF AND COMPOSITION FOR DIAGNOSIS OR TREATMENT OF CANCER CONTAINING THE SAME AS AN ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 14/063724
[patent_app_country] => US
[patent_app_date] => 2013-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9002
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14063724
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/063724 | N3S1 chelator-folate derivatives, preparation method thereof and composition for diagnosis or treatment of cancer containing the same as an active ingredient | Oct 24, 2013 | Issued |
Array
(
[id] => 10481976
[patent_doc_number] => 20150366993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/650355
[patent_app_country] => US
[patent_app_date] => 2013-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10782
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14650355
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/650355 | Compositions and methods for treatment of cancer | Oct 15, 2013 | Issued |
Array
(
[id] => 10353612
[patent_doc_number] => 20150238617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'SILK RESERVOIRS FOR SUSTAINED DELIVERY OF ANTI-CANCER AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/431067
[patent_app_country] => US
[patent_app_date] => 2013-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 30160
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431067
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431067 | SILK RESERVOIRS FOR SUSTAINED DELIVERY OF ANTI-CANCER AGENTS | Oct 10, 2013 | Abandoned |
Array
(
[id] => 9989154
[patent_doc_number] => 09034351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-19
[patent_title] => 'Compositions and methods for the treatment of skin diseases'
[patent_app_type] => utility
[patent_app_number] => 14/034358
[patent_app_country] => US
[patent_app_date] => 2013-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25106
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14034358
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/034358 | Compositions and methods for the treatment of skin diseases | Sep 22, 2013 | Issued |
| 14/000232 | BIODEGREDATION SUPPRESSION SOLUTION FOR FORENSIC SAMPLES | Aug 18, 2013 | Abandoned |
| 13/964856 | COPOLYMER-1 IMPROVEMENTS IN COMPOSITIONS OF COPOLYMERS | Aug 11, 2013 | Abandoned |
Array
(
[id] => 10297584
[patent_doc_number] => 20150182583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'METHODS FOR TREATMENT AND PREVENTION OF TAUOPATHIES BY INHIBITING ENDOTHELIN RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 14/419807
[patent_app_country] => US
[patent_app_date] => 2013-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12047
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419807
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419807 | METHODS FOR TREATMENT AND PREVENTION OF TAUOPATHIES BY INHIBITING ENDOTHELIN RECEPTORS | Aug 5, 2013 | Abandoned |
Array
(
[id] => 10443134
[patent_doc_number] => 20150328147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'METHOD FOR INTRODUCING BIOLOGICALLY ACTIVE SUBSTANCES INTO THE BRAIN'
[patent_app_type] => utility
[patent_app_number] => 14/419724
[patent_app_country] => US
[patent_app_date] => 2013-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4325
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419724
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/419724 | METHOD FOR INTRODUCING BIOLOGICALLY ACTIVE SUBSTANCES INTO THE BRAIN | Aug 4, 2013 | Abandoned |
Array
(
[id] => 9450100
[patent_doc_number] => 20140121270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'FORMULATIONS AND METHODS TO PROVIDE NUTRITION TO HUMAN AND OTHER PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/957872
[patent_app_country] => US
[patent_app_date] => 2013-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23840
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13957872
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/957872 | FORMULATIONS AND METHODS TO PROVIDE NUTRITION TO HUMAN AND OTHER PATIENTS | Aug 1, 2013 | Abandoned |
Array
(
[id] => 9198856
[patent_doc_number] => 20130338171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties'
[patent_app_type] => utility
[patent_app_number] => 13/956463
[patent_app_country] => US
[patent_app_date] => 2013-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 69149
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13956463
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/956463 | Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties | Jul 31, 2013 | Abandoned |
Array
(
[id] => 9569927
[patent_doc_number] => 20140187640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS'
[patent_app_type] => utility
[patent_app_number] => 13/952028
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 32789
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952028
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/952028 | N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress | Jul 25, 2013 | Issued |
Array
(
[id] => 9175473
[patent_doc_number] => 20130317458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'DRUG DELIVERY DEVICES FOR DELIVERY OF OCULAR THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/947564
[patent_app_country] => US
[patent_app_date] => 2013-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 97
[patent_figures_cnt] => 97
[patent_no_of_words] => 23748
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13947564
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/947564 | Drug delivery devices for delivery of ocular therapeutic agents | Jul 21, 2013 | Issued |
Array
(
[id] => 9134464
[patent_doc_number] => 20130295178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES'
[patent_app_type] => utility
[patent_app_number] => 13/938777
[patent_app_country] => US
[patent_app_date] => 2013-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11033
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13938777
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/938777 | FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES | Jul 9, 2013 | Abandoned |
Array
(
[id] => 11546762
[patent_doc_number] => 09615582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-11
[patent_title] => 'Pressurized, sprayable aqueous alcoholic microbicidal compositions comprising zinc ions'
[patent_app_type] => utility
[patent_app_number] => 13/979982
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29130
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979982
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/979982 | Pressurized, sprayable aqueous alcoholic microbicidal compositions comprising zinc ions | Jun 27, 2013 | Issued |
Array
(
[id] => 9588846
[patent_doc_number] => 08778385
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-07-15
[patent_title] => 'Medicated animal food composition'
[patent_app_type] => utility
[patent_app_number] => 13/923834
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1986
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923834
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/923834 | Medicated animal food composition | Jun 20, 2013 | Issued |
Array
(
[id] => 10898161
[patent_doc_number] => 08921374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-30
[patent_title] => 'Itraconazole compositions and dosage forms, and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 13/924222
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 60654
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13924222
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/924222 | Itraconazole compositions and dosage forms, and methods of using the same | Jun 20, 2013 | Issued |
Array
(
[id] => 9108284
[patent_doc_number] => 20130281416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/921879
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12684
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921879
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/921879 | PHARMACEUTICAL COMPOSITION | Jun 18, 2013 | Abandoned |
Array
(
[id] => 10634469
[patent_doc_number] => 09351956
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-05-31
[patent_title] => 'Pharmaceutical composition comprising an enantiomer of lipoamide and derivatives thereof and method of use'
[patent_app_type] => utility
[patent_app_number] => 13/922064
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6758
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922064
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/922064 | Pharmaceutical composition comprising an enantiomer of lipoamide and derivatives thereof and method of use | Jun 18, 2013 | Issued |
Array
(
[id] => 9108572
[patent_doc_number] => 20130281705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/920579
[patent_app_country] => US
[patent_app_date] => 2013-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41571
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13920579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/920579 | Compounds for the treatment of metabolic disorders | Jun 17, 2013 | Issued |